HealthBeacon opens a Green Labs facility in Dublin
"Novartis are proud to partner with HealthBeacon on this project," said Audrey Derveloy, Country President of Novartis in Ireland
Sector
Health
1063 stories · page 35 of 54
PharmaDrug advances DMT-analogue glaucoma program with fabrication of medical device to lower intraocular pressure
The company said a head-to-head drug elution study of its three undisclosed DMT-analogue candidates has now been completed while supportive cell-based biocompatibility has been examined
Wellbeing Digital Sciences welcomes Najla Guthrie as its new CEO
Guthrie, who has been the president and CEO of Wellbeing’s wholly-owned subsidiary KGK Science Inc since 1997, has been appointed to lead the development of an evolved competitive strategy
Wellteq Digital Health appoints health education veteran Andrew Hvizd as head of growth for its North American division
The company said Hvizd is expected to be instrumental in acquiring strategic partnerships and accelerating sustainable revenue growth
HealthBeacon sees sharp increase in revenues
HealthBeacon is expecting revenues to grow ten-fold by the end of next year
Antibiotic-resistant infections: What are they and why do we care?
Drug-resistant infections will cause the death of an estimated 10mln people per year across the globe by 2050
Irwin Naturals announces strategy to add new mental health treatments and collaborate with third-party payors
The company intends to expand treatment options at its clinics by offering a broad portfolio of powerful next-generation therapies, including the psychedelic ketamine
Wellbeing Digital Sciences says KGK Science clinical study for Shakeology validates weight loss benefits
The 12-week, randomized, double-blinded and placebo-controlled clinical trial included a sample of 206 overweight and obese adults from four different locations in the US and Canada
Wellbeing Digital Sciences says its KGK Science subsidiary engaged by Lophos Pharmaceuticals for novel peyote study
“Peyote and mescaline in general are currently underrepresented in the psychedelic medicine sector, given their traditional medicinal uses," said Najla Guthrie, president and CEO of KGK
Wellbeing Digital Sciences sees 2Q revenue of C$1.7M in first reporting period as it continues to grow mental wellness treatment clinics
The company said it has acquired 15 ketamine-enhanced mental wellness treatment clinics across North America with letters of intent signed for an additional clinic
Irwin Naturals completes acquisition of Midwest Ketafusion in Iowa
Midwest Ketafusion, a profitable ketamine clinic with a strong track record, will be rebranded as ‘Emergence by Irwin Naturals
Irwin Naturals aims to become household name in the psychedelic mental health industry
“We sell nutraceuticals to some of the biggest publicly traded retailers, we've been around 28 years, and we're a household name,” the company's CEO Klee Irwin told Proactive
SpectrumX fires the starting pistol on £50mln London IPO
It is understood the group has submitted its prospectus to the London Stock Exchange ahead of a float in late spring
Wellbeing Digital Sciences appoints Najla Guthrie as CEO effective March 31
Guthrie is the current Chief Research Officer and president of KGK Science Inc and has led it to become a leading North American contract research organization that primarily provides high-quality clinical research trials with a focus on th
Pathway Health to acquire assets of National Cannabinoid Clinics; transaction expected to close in 2Q 2022
"The potential tuck-in acquisition of NCC's operating assets will continue to expand the number of patients across Canada that have access to our products and services," said Ken Yoon, CEO of Pathway Health
NA Proactive news snapshot: MAS Gold, ION Energy, Kontrol Technologies, Snowline Gold UPDATE ...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
Wellbeing Digital Sciences says IRP Health subsidiary wins approval from Veterans Affairs Canada for Reactivation program
"This brings us one step closer to achieving our goal of a Canadian wide network of purpose-built programs for veterans and first responders who desperately need access to care," said Wellbeing interim CEO Adam Deffett
Braxia Scientific generates double-digit year-over-year revenue increase in its fiscal 3Q 2022
For the three-month period ending December 31, 2021, the company recorded revenue of $324,902, reflecting a 13.3% increase from the year-ago quarter thanks to sales of ketamine-infusion treatments
Wellbeing Digital Sciences delivers first IV ketamine treatment under new in-patient program
“The company has always wanted to make a positive and significant impact on mental health and this brings us one step closer,” Wellbeing interim CEO Adam Deffett said